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Pain may be described as a response to the sensitization of specific 
peripheral neurons, the nociceptors. These sensations are encoded 
by the peripheral nervous system (PNC) and central nervous system 
(SNC) by a conversion of all the information into frequency-
modulated signals. 
The comprehension of its pathophysiology permitted unveiling the 
protective role of this mechanism in maintaining body homeostasis 
and to protect against damaging stimuli.1 Furthermore, most of 
the pain occurring in dentistry including dental pain, trigeminal 
neuralgia, temporomandibular joint pain, muscle pain and headache 
are associated to the structures that are covered by sensory innervation 
from the trigeminal nerve. Moreover, effective pain control stills 
remain a challenge to the dental practice, especially, when referring 
to post-operatory conditions when the patient’s cooperation and 
anxiety are limiting conditions. 
Analgesia may be achieved with pharmacological interventions 
that include different analgesic therapies (e.g. non-steroidal anti-
inf lammatory drugs (NSAIDs), opioids, NMDA receptor blockers) 
and drugs regimens (e.g. preemptive, perioperative, postoperative 
analgesia). Depending on the nature and intensity of the expected pain 
different pharmacological protocols are recommended and in some 
situations, we may focus in initiating treatment before the signals are 
transmitted to the CNS, what is called preemptive analgesia.2
 The idea is based on the concept that noxious signals should be 
blocked prior surgical assessment and this may prevent the input 
from the periphery and it continues throughout the healing process. 
The pharmacological protocol may vary depending on the patients 
medical conditions and required treatment, but a classical intervention 
may include the use of a preoperative dose of a traditional NSAIDs 
e.g. ibuprofen, diclofenac, piroxicam, etc. 
The oral administration of coxibs (e.g celecoxib 100mg, 200mg 
or 400mg) may be effective in controlling pain in dentistry and in 
terms of pharmacokinetics it is a good option for the clinician due 
to its rapid absorption and only a 2 to 4 hours delay to achieve the 
maximum serum concentration.
Furthermore, the drug is well tolerated without food and has 
low occurrence of side effects, and does not interfere with platelet 
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aggregation, preventing hemorrhagic episodes. 
Combining pre-incisional long-lasting local regional 
block anesthesia with 0.5% bupivacaine 1:200.000 
epinephrine seems to decrease the perception of 
postoperative pain3 as a safe and valuable alternative to 
use as a coadjuvant to anti-inf lammatory agents. Other 
protocols may consider nitrous oxide analgesia during 
surgeries or even the use of corticosteroids targeting 
swelling and consequently avoiding postoperative pain.4 
During the last years, preemptive analgesia has been 
questioned for its real efficacy,5 but what we should 
consider to establish certainty, and in developing 
individual protocols for our patients we do not discard 
the possibility of introducing multimodal analgesic 
techniques or even promote synergic antinociceptive 
drug effects.
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